Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial
Authors
Keywords
-
Journal
Trials
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-17
DOI
10.1186/s13063-020-4116-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ticagrelor – toward more efficient platelet inhibition and beyond
- (2018) Michał Kubisa et al. Therapeutics and Clinical Risk Management
- When small vessels become big problems! Microvascular dysfunction in NSTEMI
- (2018) Elizabeth P Held et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy
- (2017) Dorota Danielak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations
- (2016) Leonardo De Luca et al. AMERICAN HEART JOURNAL
- The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
- (2016) Angeliki Papapanagiotou et al. CURRENT PHARMACEUTICAL DESIGN
- Dual antiplatelet therapy after coronary stenting
- (2016) Yongwhi Park et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve
- (2016) Abdul Hakeem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors
- (2016) Fabiana Rollini et al. THROMBOSIS AND HAEMOSTASIS
- Switching P2Y12-receptor inhibitors in patients with coronary artery disease
- (2015) Fabiana Rollini et al. Nature Reviews Cardiology
- Adenosine
- (2014) Jamie Layland et al. JACC-Cardiovascular Interventions
- Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts
- (2013) Xi-Ming Yang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
- (2013) Dimitrios Alexopoulos et al. Circulation-Cardiovascular Interventions
- Impact of Coronary Microvascular Function on Long-term Cardiac Mortality in Patients With Acute ST-Segment–Elevation Myocardial Infarction
- (2013) Tim P. van de Hoef et al. Circulation-Cardiovascular Interventions
- Vasodilatory Capacity of the Coronary Microcirculation is Preserved in Selected Patients With Non–ST-Segment–Elevation Myocardial Infarction
- (2013) Jamie Layland et al. Circulation-Cardiovascular Interventions
- Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
- (2013) Ann Wittfeldt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor induces adenosine triphosphate release from human red blood cells
- (2012) Jenny Öhman et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
- (2012) Xi-Ming Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease
- (2012) Bernard De Bruyne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)
- (2011) Robert F. Storey et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model
- (2011) J. J. J. van Giezen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- A tutorial on pilot studies: the what, why and how
- (2010) Lehana Thabane et al. BMC Medical Research Methodology
- Cardioprotection With Adenosine-Regulating Agent, GP531: Effects on No-Reflow, Infarct Size, and Blood Flow Following Ischemia/ Reperfusion in the Rabbit
- (2010) Sharon L. Hale et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation of Platelet Inhibition by Tirofiban in Patients Stratified According to Aspirin and Clopidogrel Responsiveness
- (2010) Gianluca Campo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia
- (2010) Carl J. Pepine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of ischemic preconditioning and arterial collateral flow on ST-segment elevation and QRS complex prolongation in a canine model of acute coronary occlusion
- (2008) James S. Floyd et al. JOURNAL OF ELECTROCARDIOLOGY
- Ethanol Abolishes Ischemic Preconditioning in Humans
- (2008) Giampaolo Niccoli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The MRC breathlessness scale
- (2008) C. Stenton OCCUPATIONAL MEDICINE-OXFORD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started